// App-Quantinova.ai

TCT-178 : Primary Endpoint Results from the TAXUS Element Post-Approval Surveillance Study (TE-PROVE): 1-Year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium, Paclitaxel-Eluting Stent

Researchers

Presenter

  • Corrado Tamburino

Principal Investigators

  • Andrejs Erglis

  • Ian Menown

  • Ivan G Horvath

  • Guillame Lecoq

  • Raul Moreno

  • Timothy J Gilbert

  • Davide Capodanno

  • Dominic J Allocco

  • Keith D Dawkins

Medical Centers

  • Heart Institute, University of Pecs, Pecs, Hungary

  • Craigavon Area Hospital, Craigavon, United Kingdom

  • CHP St. Martin, Caen,

  • University Hospital La Paz, Madrid, Spain

  • Norfolk and Norwich University Hospitals NHS Trust, Norwich, United Kingdom.

  • University of Catania, Catania, Italy

Locations

  • Latvia

  • Italy

  • Spain

  • United Kingdom

  • Hungary

Companies

  • Boston Scientific

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Paclitaxel

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved